Marino M J, Awad H, Poisik O, Wittmann M, Conn P J
Department of Pharmacology, Emory University School of Medicine, Atlanta, Georgia, USA.
Amino Acids. 2002;23(1-3):185-91. doi: 10.1007/s00726-001-0127-1.
Our current understanding of the circuitry of the basal ganglia, and the pathophysiology of Parkinson's disease has led to major breakthroughs in the treatment of this debilitating movement disorder. Unfortunately, there are significant problems with the currently available pharmacological therapies that focus on dopamine replacement or dopaminergic agonists. Because of this, much effort has been focused on developing novel targets for the treatment of Parkinson's disease. The metabotropic glutamate receptors are a family of G-protein coupled receptors activated by glutamate. These receptors are differentially distributed throughout the basal ganglia in a manner suggesting that they may provide novel targets for the treatment of movement disorders. In this review we summarize anatomical and physiological data from our work and the work of other laboratories describing the distribution and physiological roles of metabotropic glutamate receptors in the basal ganglia with emphasis on possible therapeutic targets.
我们目前对基底神经节神经回路以及帕金森病病理生理学的理解,已在这种使人衰弱的运动障碍的治疗方面取得了重大突破。不幸的是,目前可用的专注于多巴胺替代或多巴胺能激动剂的药物疗法存在重大问题。因此,大量努力都集中在开发治疗帕金森病的新靶点上。代谢型谷氨酸受体是一类由谷氨酸激活的G蛋白偶联受体。这些受体以一种表明它们可能为运动障碍治疗提供新靶点的方式,在整个基底神经节中呈差异分布。在这篇综述中,我们总结了来自我们自己以及其他实验室的工作中的解剖学和生理学数据,这些数据描述了代谢型谷氨酸受体在基底神经节中的分布和生理作用,并着重介绍了可能的治疗靶点。